NCT04356755View on ClinicalTrials.gov

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Systemic Sclerosis
Interventions
DRUG

AdMSC

At day 0, patients will have AdMSC injections in their ischemic DU. Patients will be followed-up for 16 weeks

DRUG

Placebo

At day 0, patients will have placebo injections in their ischemic DU. Patients will be followed-up for 16 weeks

Trial Locations (7)

31059

RECRUITING

CHU de Toulouse - Hôpital PURPAN-TSA, Toulouse

Unknown

NOT_YET_RECRUITING

Grenoble Hospital, Grenoble

NOT_YET_RECRUITING

Lille Hopsital, Lille

NOT_YET_RECRUITING

Marseille Hospital, Marseille

NOT_YET_RECRUITING

Montpellier Hospital, Montpellier

NOT_YET_RECRUITING

Nantes Hospital, Nantes

NOT_YET_RECRUITING

Poitiers Hospital, Poitiers

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER